https://www.databridgemarketre....search.com/reports/g

Adalimumab Biosimilar Market Size & Growth Drivers By 2030

The adalimumab biosimilar market which was USD 598.30 million in 2022, crosses USD 3431.48 million by 2030, following a CAGR of 24.4% by the forecasted period.